WS #16188
Adidas reported a strong Q3 with sales up 9% YoY and operating profit rising 37%, significantly aided by a €200M refund from US tariff claims. Halliburton also beat Q3 estimates with $5.7B in revenue, driven by robust international growth that offset North American weakness. In M&A activity, EQT and KKR are in advanced talks to acquire testing firm Qiagen, while Myriad Genetics offloaded its struggling prenatal unit to Labcorp for $210M.
Corporate Earnings & M&A
Adidas reported a strong Q3 with sales up 9% YoY and operating profit rising 37%, significantly aided by a €200M refund from US tariff claims. Halliburton also beat Q3 estimates with $5.7B in revenue, driven by robust international growth that offset North American weakness. In M&A activity, EQT and KKR are in advanced talks to acquire testing firm Qiagen, while Myriad Genetics offloaded its struggling prenatal unit to Labcorp for $210M.